RESUMEN
The large outbreak of coronavirus disease 2019 (COVID-19) is spreading all over the world rapidly. There have recently been publications in the literature regarding the relationship between COVID-19 and Kawasaki disease, but there is no sufficient knowledge about the treatment and follow-up.
Asunto(s)
Antivirales/uso terapéutico , Tratamiento Farmacológico de COVID-19 , Hipoxia/terapia , Lopinavir/uso terapéutico , Síndrome Mucocutáneo Linfonodular/tratamiento farmacológico , Terapia por Inhalación de Oxígeno , Ritonavir/uso terapéutico , Ampicilina/uso terapéutico , Antibacterianos/uso terapéutico , Anticoagulantes/uso terapéutico , Azitromicina/uso terapéutico , COVID-19/complicaciones , COVID-19/diagnóstico por imagen , COVID-19/fisiopatología , Prueba de Ácido Nucleico para COVID-19 , Prueba Serológica para COVID-19 , Niño , Combinación de Medicamentos , Enoxaparina/uso terapéutico , Humanos , Hidroxicloroquina/uso terapéutico , Hipoxia/etiología , Hipoxia/fisiopatología , Inmunoglobulinas Intravenosas/uso terapéutico , Factores Inmunológicos/uso terapéutico , Pulmón/diagnóstico por imagen , Masculino , Síndrome Mucocutáneo Linfonodular/etiología , Síndrome Mucocutáneo Linfonodular/fisiopatología , Oseltamivir/uso terapéutico , Sulbactam/uso terapéutico , Tomografía Computarizada por Rayos XRESUMEN
Leptospirosis, a zoonosis, is characterized by a wide range of clinical and laboratory findings, varying from self-limiting infection to potentially fatal disease. Leptospirosis-related clinical manifestations, except for Weil's disease, may often be overlooked due to their nonspecificity in children. Additionally, many health-care professionals lack awareness of leptospirosis. This paper presents a case of leptospirosis that was initially misdiagnosed as staphylococcal toxic shock syndrome. The literature on this topic is also reviewed.